Literature DB >> 33668706

Dequalinium Chloride Effectively Disrupts Bacterial Vaginosis (BV) Gardnerella spp. Biofilms.

Carlos Gaspar1,2,3, Joana Rolo1, Nuno Cerca4, Rita Palmeira-de-Oliveira1,2,3,5, José Martinez-de-Oliveira1, Ana Palmeira-de-Oliveira1,2,3.   

Abstract

Bacterial vaginosis (BV) is the most frequent vaginal infection worldwide. It is caused by the overgrowth of anaerobic vaginal pathogens such as Gardnerella spp. BV has been associated with the occurrence of dense multispecies biofilms on the vaginal mucosa. Treatment of biofilm-associated infections such as BV is challenging. In this study, we have tested the role of a quaternary ammonium compound, dequalinium chloride (DQC), in the eradication of Gardnerella spp. biofilms. The effects of the test substance on the biomass and the metabolic activity of the biofilm of Gardnerella spp. were assessed in vitro using a microtiter plate assay. In addition, the effect of DQC on the Gardnerella spp. biofilm was further assessed by using scanning electron microscopy and confocal laser scanning microscopy. The results showed that DQC was particularly effective in the destruction of BV-associated Gardnerella spp. biotypes, impacting both their biomass and metabolic activity. In addition, the disruption of biofilm architecture was evident and was probably caused by multiple mechanisms of action. We conclude that DQC is an antibiofilm agent and is able to efficiently destroy Gardnerella spp. BV-associated biofilms. Therefore, it is a valid option for BV therapy and has the potential to prevent BV recurrences.

Entities:  

Keywords:  bacterial vaginosis; biofilm; dequalinium chloride; recurrence prevention; treatment

Year:  2021        PMID: 33668706      PMCID: PMC7996269          DOI: 10.3390/pathogens10030261

Source DB:  PubMed          Journal:  Pathogens        ISSN: 2076-0817


  23 in total

1.  Antimicrobial activity of dequalinium chloride against leading germs of vaginal infections.

Authors:  Vera Della Casa; Harald Noll; Susanne Gonser; Philipp Grob; Federico Graf; Gabriele Pohlig
Journal:  Arzneimittelforschung       Date:  2002

2.  A comparison of dequalinium chloride vaginal tablets (Fluomizin®) and clindamycin vaginal cream in the treatment of bacterial vaginosis: a single-blind, randomized clinical trial of efficacy and safety.

Authors:  Ernst Rainer Weissenbacher; Gilbert Donders; Vit Unzeitig; Begoña Martinez de Tejada; Stefan Gerber; Michael Halaška; Jiří Špaček
Journal:  Gynecol Obstet Invest       Date:  2011-12-24       Impact factor: 2.031

3.  Optimization of culture conditions for Gardnerella vaginalis biofilm formation.

Authors:  Daniela Machado; Ana Palmeira-de-Oliveira; Nuno Cerca
Journal:  J Microbiol Methods       Date:  2015-09-14       Impact factor: 2.363

4.  Salts of decamethylene-bis-4-aminoquinaldinium (dequadin); a new antimicrobial agent.

Authors:  M BABBS; H O COLLIER; W C AUSTIN; M D POTTER; E P TAYLOR
Journal:  J Pharm Pharmacol       Date:  1956-02       Impact factor: 3.765

Review 5.  Pathogenesis of mucosal biofilm infections: challenges and progress.

Authors:  Anna Dongari-Bagtzoglou
Journal:  Expert Rev Anti Infect Ther       Date:  2008-04       Impact factor: 5.091

6.  Comparison of multiple methods for quantification of microbial biofilms grown in microtiter plates.

Authors:  Elke Peeters; Hans J Nelis; Tom Coenye
Journal:  J Microbiol Methods       Date:  2007-11-21       Impact factor: 2.363

Review 7.  Treatment of bacterial vaginosis: what we have and what we miss.

Authors:  Gilbert G G Donders; Jana Zodzika; Dace Rezeberga
Journal:  Expert Opin Pharmacother       Date:  2014-02-28       Impact factor: 3.889

8.  Effects of quaternary-ammonium-based formulations on bacterial community dynamics and antimicrobial susceptibility.

Authors:  Andrew J McBain; Ruth G Ledder; Louise E Moore; Carl E Catrenich; Peter Gilbert
Journal:  Appl Environ Microbiol       Date:  2004-06       Impact factor: 4.792

Review 9.  Use of locally delivered dequalinium chloride in the treatment of vaginal infections: a review.

Authors:  Werner Mendling; Ernst Rainer Weissenbacher; Stefan Gerber; Valdas Prasauskas; Philipp Grob
Journal:  Arch Gynecol Obstet       Date:  2015-10-27       Impact factor: 2.344

10.  Gardnerella vaginalis Enhances Atopobium vaginae Viability in an in vitro Model.

Authors:  Joana Castro; Aliona S Rosca; Piet Cools; Mario Vaneechoutte; Nuno Cerca
Journal:  Front Cell Infect Microbiol       Date:  2020-03-04       Impact factor: 5.293

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.